Xinhe Shan

2.1k total citations
7 papers, 193 citations indexed

About

Xinhe Shan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Xinhe Shan has authored 7 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Xinhe Shan's work include CAR-T cell therapy research (4 papers), Immune cells in cancer (2 papers) and Allelopathy and phytotoxic interactions (1 paper). Xinhe Shan is often cited by papers focused on CAR-T cell therapy research (4 papers), Immune cells in cancer (2 papers) and Allelopathy and phytotoxic interactions (1 paper). Xinhe Shan collaborates with scholars based in United States and China. Xinhe Shan's co-authors include James R. McBride, Tianquan Lian, Jinquan Chen, Kaifeng Wu, Guijie Liang, Saar Gill, Degui Kong, Zheyuan Chen, Sunita D. Nasta and Jakub Svoboda and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Xinhe Shan

5 papers receiving 193 citations

Peers

Xinhe Shan

ONCOL

EEE

MC

BE

GENET

Menglei Zhu United States

Ruixiang Xia China

Zelin Wang China

Jian Ge China

Chang-Kyung Kim United States

Galen F. Gao United States

Yiyang Xu United States

Elizaveta Reznichenko United States

Ruyuan Li China

Pingping Qu United States

Menglei Zhu United States

Xinhe Shan

99 ×0.9

ONCOL

32 ×0.5

EEE

34 ×0.6

MC

13 ×0.3

BE

11 ×0.3

GENET

Citations per year, relative to Xinhe Shan Xinhe Shan (= 1×) peers Menglei Zhu

Countries citing papers authored by Xinhe Shan

Since Specialization

Citations

This map shows the geographic impact of Xinhe Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhe Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhe Shan more than expected).

Fields of papers citing papers by Xinhe Shan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinhe Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhe Shan. The network helps show where Xinhe Shan may publish in the future.

Co-authorship network of co-authors of Xinhe Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Xinhe Shan. A scholar is included among the top collaborators of Xinhe Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinhe Shan. Xinhe Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Welty, Nathan E., et al.. (2024). Engineering Myeloid Hematopoiesis By Nonviral Chimeric Antigen Receptor Knock-in to CD33 Enhances T Cell Infiltration in the Tumor Microenvironment. Blood. 144(Supplement 1). 85–85. 1 indexed citations

2.

Shan, Xinhe & Sandra P. Susanibar-Adaniya. (2024). Comparative Outcomes of Functional High-Risk Multiple Myeloma Patients with and without High-Risk Features at Diagnosis: A Commpass Study Analysis. Blood. 144(Supplement 1). 80–80.

3.

Yang, Chaowei, et al.. (2022). Allelopathic Toxicity of Cyanamide Could Control Amaranth (Amaranthus retroflexus L.) in Alfalfa (Medicago sativa L.) Field. Molecules. 27(21). 7347–7347.

4.

Gabrusiewicz, Konrad, Nicholas R. Anderson, Xueqing Maggie Lu, et al.. (2020). Abstract B65: CT-0508, a novel CAR macrophage product directed against HER2, promotes a proinflammatory tumor microenvironment. Cancer Immunology Research. 8(3_Supplement). B65–B65. 4 indexed citations

5.

Frey, Noelle V., Saar Gill, Elizabeth O. Hexner, et al.. (2020). Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 38(25). 2862–2871. 126 indexed citations

6.

Klichinsky, Michael, Konrad Gabrusiewicz, Nicholas R. Anderson, et al.. (2020). Abstract 3242: CT-0508 is an anti-HER2 chimeric antigen receptor (CAR) macrophage with targeted anti-tumor activity that promotes a pro-inflammatory solid tumor microenvironment. Cancer Research. 80(16_Supplement). 3242–3242. 3 indexed citations

7.

Wu, Kaifeng, Guijie Liang, Degui Kong, et al.. (2015). Quasi-type II CuInS₂/CdS core/shell quantum dots. Chemical Science. 7(2). 1238–1244. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact